دورية أكاديمية
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors.
العنوان: | A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. |
---|---|
المؤلفون: | Lanning BR; The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd. La Jolla, CA, 92307., Whitby LR; The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd. La Jolla, CA, 92307., Dix MM; The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd. La Jolla, CA, 92307., Douhan J; Pfizer Worldwide Research and Development, 200 Cambridge Park Drive, Cambridge, MA 02140., Gilbert AM; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340., Hett EC; Pfizer Worldwide Research and Development, 200 Cambridge Park Drive, Cambridge, MA 02140., Johnson TO; Pfizer Worldwide Research and Development, 10770 Science Park Drive, San Diego, CA 92121., Joslyn C; The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd. La Jolla, CA, 92307., Kath JC; Pfizer Worldwide Research and Development, 10770 Science Park Drive, San Diego, CA 92121., Niessen S; Pfizer Worldwide Research and Development, 10770 Science Park Drive, San Diego, CA 92121., Roberts LR; Pfizer Worldwide Research and Development, 200 Cambridge Park Drive, Cambridge, MA 02140., Schnute ME; Pfizer Worldwide Research and Development, 200 Cambridge Park Drive, Cambridge, MA 02140., Wang C; The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd. La Jolla, CA, 92307., Hulce JJ; The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd. La Jolla, CA, 92307., Wei B; Pfizer Worldwide Research and Development, 1 Burtt Rd, Andover, MA 01810., Whiteley LO; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340., Hayward MM; Pfizer Worldwide Research and Development, Eastern Point Road, Groton, CT 06340., Cravatt BF; The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd. La Jolla, CA, 92307. |
المصدر: | Nature chemical biology [Nat Chem Biol] 2014 Sep; Vol. 10 (9), pp. 760-767. Date of Electronic Publication: 2014 Jul 13. |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: New York, NY : Nature Pub. Group, [2005]- |
مواضيع طبية MeSH: | Protein Kinase Inhibitors/*pharmacology , Proteome/*genetics, Adenine/analogs & derivatives ; Agammaglobulinaemia Tyrosine Kinase ; Cell Line, Tumor ; Cell Survival/drug effects ; Cysteine/chemistry ; Genes, erbB-1/genetics ; Humans ; Kinetics ; Piperidines ; Protein Kinases/metabolism ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Pyrazoles/pharmacology ; Pyrimidines/pharmacology ; Signal Transduction/drug effects ; Signal Transduction/genetics |
مستخلص: | Kinases are principal components of signal transduction pathways and the focus of intense basic and drug discovery research. Irreversible inhibitors that covalently modify non-catalytic cysteines in kinase active sites have emerged as valuable probes and approved drugs. Many protein classes, however, have functional cysteines, and therefore understanding the proteome-wide selectivity of covalent kinase inhibitors is imperative. Here, we accomplish this objective using activity-based protein profiling coupled with quantitative MS to globally map the targets, both specific and nonspecific, of covalent kinase inhibitors in human cells. Many of the specific off-targets represent nonkinase proteins that, notably, have conserved active site cysteines. We define windows of selectivity for covalent kinase inhibitors and show that, when these windows are exceeded, rampant proteome-wide reactivity and kinase target-independent cell death conjointly occur. Our findings, taken together, provide an experimental road map to illuminate opportunities and surmount challenges for the development of covalent kinase inhibitors. |
References: | J Med Chem. 2000 Apr 6;43(7):1380-97. (PMID: 10753475) Br J Haematol. 2013 Apr;161(1):43-56. (PMID: 23360303) ChemMedChem. 2007 Jan;2(1):58-61. (PMID: 17154430) Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):173-8. (PMID: 24347635) Curr Opin Chem Biol. 2010 Aug;14(4):475-80. (PMID: 20609616) Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6811-6. (PMID: 21398589) ACS Chem Biol. 2013 Jul 19;8(7):1590-9. (PMID: 23701408) Nat Methods. 2011 Nov 06;9(1):84-9. (PMID: 22056678) Nat Chem Biol. 2008 Jul;4(7):405-7. (PMID: 18488014) Nature. 2010 Dec 9;468(7325):790-5. (PMID: 21085121) Annu Rev Biochem. 2008;77:383-414. (PMID: 18366325) Comb Chem High Throughput Screen. 2007 Sep;10(8):652-66. (PMID: 18045078) Science. 2002 Dec 6;298(5600):1912-34. (PMID: 12471243) J Med Chem. 2012 Jul 26;55(14):6243-62. (PMID: 22621397) J Med Chem. 2009 Mar 12;52(5):1231-46. (PMID: 19203292) Chem Biol. 2009 Apr 24;16(4):411-20. (PMID: 19389627) FEBS Lett. 2013 Jun 27;587(13):1870-7. (PMID: 23684650) ACS Chem Biol. 2013 Feb 15;8(2):283-96. (PMID: 23163700) Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80. (PMID: 20615965) Chem Biol. 2005 Jun;12(6):621-37. (PMID: 15975507) Nat Chem Biol. 2012 Dec;8(12):999-1007. (PMID: 23103940) Nat Rev Mol Cell Biol. 2006 Dec;7(12):952-8. (PMID: 17139335) Nat Chem Biol. 2009 Sep;5(9):616-24. (PMID: 19690537) Elife. 2013 Jul 09;2:e00712. (PMID: 23853713) Mol Cancer Ther. 2012 Mar;11(3):784-91. (PMID: 22228822) Drugs. 2014 Feb;74(2):263-71. (PMID: 24464309) Nat Biotechnol. 2001 Mar;19(3):242-7. (PMID: 11231557) Onco Targets Ther. 2013;6:135-43. (PMID: 23493883) J Am Chem Soc. 2011 Oct 19;133(41):16605-16. (PMID: 21899313) Angew Chem Int Ed Engl. 2002 Jul 15;41(14):2596-9. (PMID: 12203546) Blood. 2012 Feb 2;119(5):1182-9. (PMID: 22180443) Biochem Pharmacol. 2012 Dec 1;84(11):1388-99. (PMID: 22885287) Chem Biol. 2013 Feb 21;20(2):146-59. (PMID: 23438744) Oncogene. 2008 Aug 7;27(34):4702-11. (PMID: 18408761) Future Med Chem. 2010 Jun;2(6):949-64. (PMID: 20640225) Science. 2005 May 27;308(5726):1318-21. (PMID: 15919995) Drug Metab Dispos. 2009 Sep;37(9):1970-7. (PMID: 19487250) Nat Chem Biol. 2013 Apr;9(4):200-5. (PMID: 23508173) Blood. 2014 Feb 20;123(8):1207-13. (PMID: 24311722) Chem Res Toxicol. 2007 Jun;20(6):859-67. (PMID: 17480101) Cell Signal. 2013 Jan;25(1):106-12. (PMID: 22975686) Bioorg Med Chem Lett. 2008 Nov 15;18(22):5916-9. (PMID: 18667312) Blood. 2011 Jun 9;117(23):6287-96. (PMID: 21422473) J Am Chem Soc. 2003 Apr 23;125(16):4686-7. (PMID: 12696868) J Med Chem. 2011 Mar 10;54(5):1347-55. (PMID: 21322567) J Am Chem Soc. 2010 Jan 20;132(2):656-66. (PMID: 20028024) Nat Methods. 2013 Mar;10(3):259-64. (PMID: 23396283) Nat Chem Biol. 2007 Mar;3(3):156-60. (PMID: 17259979) Nat Protoc. 2006;1(3):1112-6. (PMID: 17406391) J Pharmacol Exp Ther. 2012 Nov;343(2):342-50. (PMID: 22888144) J Med Chem. 2001 Aug 16;44(17):2719-34. (PMID: 11495584) Blood. 2012 Aug 30;120(9):1877-87. (PMID: 22689860) Nat Chem Biol. 2007 Apr;3(4):229-38. (PMID: 17334377) Nat Chem Biol. 2011 May 15;7(7):469-78. (PMID: 21572424) |
معلومات مُعتمدة: | R01 CA087660 United States CA NCI NIH HHS; R37 CA087660 United States CA NCI NIH HHS; CA087660 United States CA NCI NIH HHS |
المشرفين على المادة: | 0 (Piperidines) 0 (Protein Kinase Inhibitors) 0 (Proteome) 0 (Pyrazoles) 0 (Pyrimidines) 1X70OSD4VX (ibrutinib) EC 2.7.- (Protein Kinases) EC 2.7.10.1 (Protein-Tyrosine Kinases) EC 2.7.10.2 (Agammaglobulinaemia Tyrosine Kinase) JAC85A2161 (Adenine) K848JZ4886 (Cysteine) |
تواريخ الأحداث: | Date Created: 20140721 Date Completed: 20141021 Latest Revision: 20240610 |
رمز التحديث: | 20240610 |
مُعرف محوري في PubMed: | PMC4138289 |
DOI: | 10.1038/nchembio.1582 |
PMID: | 25038787 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1552-4469 |
---|---|
DOI: | 10.1038/nchembio.1582 |